Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
1.97
-
NAV
₹20.13
-
Fund Started
14 Sep 2023
-
Fund Size
₹2158.58 Cr
-
Exit Load
Exit load of 1%, if redeemed within 30 days.
-
1 Year
20.28%
-
3 Year
-
-
5 Year
-
-
Equity
97.30%
-
Cash
2.70%
-
Top 10 Holdings
Divi's Laboratories Ltd. | 8.56% |
Sun Pharmaceutical Industries Ltd. | 8.05% |
Lupin Ltd. | 6.07% |
Glenmark Pharmaceuticals Ltd. | 6.06% |
Max Healthcare Institute Ltd. | 5.93% |
Aster DM Healthcare Ltd. | 5.46% |
Alkem Laboratories Ltd. | 4.69% |
Anthem Biosciences Ltd. | 4.55% |
Ipca Laboratories Ltd. | 4.39% |
Cipla Ltd. | 4.27% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
-
Launch Date
14 Sep 2023
-
